Haemonetics (HAE) Accumulated Depreciation & Amortization (2010 - 2026)

Haemonetics has reported Accumulated Depreciation & Amortization for 17 years, with the latest figure at $536.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization fell 3.09% year-over-year to $536.1 million; the trailing twelve-month figure through Mar 2026 stood at $536.1 million (down 3.09% YoY), and the FY2026 full-year result was $536.1 million, down 3.09% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $536.1 million, down from $539.6 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $875.3 million in Q4 2024, with the low at $508.2 million in Q2 2025.
• Average Accumulated Depreciation & Amortization over 5 years is $618.1 million, with a median of $635.8 million recorded in 2023.
• Year-over-year, Accumulated Depreciation & Amortization soared 32.49% in 2024 and slumped 38.35% in 2025.
• Tracing HAE's Accumulated Depreciation & Amortization over 5 years: stood at $610.7 million in 2022, then rose by 8.18% to $660.6 million in 2023, then jumped by 32.49% to $875.3 million in 2024, then tumbled by 38.35% to $539.6 million in 2025, then slipped by 0.65% to $536.1 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $536.1 million (Q1 2026), $539.6 million (Q4 2025), and $522.8 million (Q3 2025), per Business Quant data.

Peer Comparison